Webinar: Cracking the Code – Successfully Delivering a Technology Transfer Project

About the Webinar

Technology Transfer is the high-stakes bridge between R&D innovation and commercial manufacturing — a process that can accelerate success or derail timelines, budgets, and compliance if mishandled.

In this power-packed webinar, we’ll demystify technology transfer and show why it’s one of the most strategic and risk-sensitive steps in pharmaceutical and biotech operations. You’ll uncover insider strategies for navigating complex CDMO partnerships, avoiding costly pitfalls, and mastering best practices that ensure flawless execution and regulatory alignment. If you’re in R&D, manufacturing, operations, small molecule drug, or biologic, this is your chance to gain actionable insights that eliminate barriers, accelerate scale-up, and safeguard product quality.

Don’t miss the opportunity to learn from experts who have successfully managed global tech transfers — because getting it right isn’t optional, it’s mission-critical.

What You’ll Learn

The Essentials of Technology Transfer (TT): Understand what TT is, why it matters, and the common triggers that initiate the process.
Execution Framework & Oversight: Learn the step-by-step methodology for TT, including CDMO selection, startup planning, and close-out strategies.
Best Practices & Regulatory Insights: Discover how to avoid common pitfalls, manage tariff impacts, and stay compliant with evolving regulatory requirements

Unable to join? Register and you will receive the recording after the live session.

Who Should Attend?

Decision makers – Determines the priorities and set the budgets and timelines.

Head of Operations / Manufacturing – Oversees production, from development to commercial scale.

R&D Leaders – Responsible for developing processes that will be transferred.

Quality Assurance & Regulatory Managers – Ensure compliance, including documentation and regulatory submissions.

Supply Chain & Procurement Managers – Involved in CDMO selection and tariff impact considerations.

Project Managers – Coordinate timelines, resources, and communication across stakeholders.

Chemistry, Manufacturing, and Controls Leaders – Critical for regulatory and technical alignment.

CDMOs Operations Directors at – External partners who execute TT.

Business Development – For strategic partnerships and outsourcing decisions.

Meet the Speakers

Rob Turner

Senior Vice President, R&D Life Sciences Consulting

View Bio
Simona Mills

Senior Director, Product Lifecycle Management

View Bio
Bob Beall

Vice President, Quality and Compliance

View Bio
Bram Lardee

Senior Director, Product LifeCycle Management

View Bio

Rob Turner

Rob Turner, Ph.D. is Senior Vice President of R&D Life Sciences Consulting at ProPharma, where he leads global program and project management. With a Ph.D. in Molecular Biophysics & Biochemistry (Yale University) and over 20 years in life sciences consulting at Accenture, Deloitte, and ProPharma, Rob has worked across nearly every R&D vertical—from Discovery and Pre-Clinical to Clinical Development, Quality Assurance, Global Medical Affairs, and Commercial across small/large molecule and devices. He combines his project management expertise with specializations in operational excellence and organizational change management, helping top pharmaceutical companies optimize processes, accelerate timelines, drive projects to completion, and ensure compliance. Rob has authored thought leadership for leading firms and recently spearheaded the relaunch of ProPharma’s Technology Transfer practice. Based in Chicagoland, he combines deep scientific expertise with strategic insight to deliver transformative solutions for life sciences organizations worldwide.

Simona Mills

Simona Mills, PMP, is the Sr. Director of Product Lifecycle Management in the Quality and Compliance service line at ProPharma. She has more than 23 years of industry experience in pharmaceuticals, biologics, and combination products. Simona previously worked for a CMO with its own generics line of parenteral products before joining ProPharma. Her expertise is in Quality (Validation, Quality, Quality Engineering, and Regulatory Affairs) and Project Management, with additional experience in facility construction/start-up, remediation, and people and project management. Since joining ProPharma, Simona has earned her PMP certification and has worked on a variety of projects, including Tech Transfer, Compliance/QMS, Inspection Readiness, Remediation, 505(b)(2) commercialization, Auditing, etc. She established and leads the Inspection Readiness/PAI Readiness services at ProPharma. Simona Mills studied Chemical Engineering at The Ohio State University.

Bob Beall

Robert has supported the development and commercialization of multiple cell therapy products and processes including decentralization of CD19+ CAR T therapies, development of hospital cellular therapy labs, including expansion of the NIH Center for Cellular Engineering, as well as the expansion of the first commercialized CAR-T therapy process capabilities. Other Cell therapy programs included remediation support for cellular and media manufacturing programs, and guidance for multiple CAR-T manufacturing automation advancements. Robert supported the COVID-19 response by establishing global safety systems for three major vaccines. He has led hundreds of international product transfers utilizing both internal transfers and CMO’s at multiple top 10 Pharmaceutical companies. He is a graduate of the Rochester Institute of Technology (RIT) with a BS in Engineering and has completed advanced degree studies as well as completing his PMP certification. He is an international speaker and author.

Bram Lardee

Mr. Lardée began his career as an Analytical Chemist in the vitamins and pharmaceuticals division at Solvay-Duphar (Netherlands), eventually advancing to the role of Analytical Expert. After several years in this position, he transitioned into Pharmaceutical Technology, where he was responsible for developing a wide range of dosage forms from toxicology and clinical phases through to market approval.

Leveraging his broad hands-on experience and strong ability to translate technical knowledge into strategic project execution, Mr. Lardée was appointed Global CMC Project Lead at Solvay Pharmaceuticals (later Abbott Healthcare Products). In this role, he supported multiple clinical programs and managed the lifecycle of marketed products.

Prior to joining ProPharma, he served as R&D Director at Centrient Pharmaceuticals, where he was technically accountable for establishing the Finished Dosage Forms franchise. Mr. Lardée brings over 35 years of experience in the pharmaceutical industry.